Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,304 Cr
up ₹36.9 Cr vs Feb 2023
- Stocks held
- 29
- unchanged
- Top 10 weight
- 62.8%
- of the portfolio in its ten largest
- Cash & debt
- 1.2%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 17
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In March 2023 it disclosed 29 stocks worth ₹4,304 Cr, up ₹36.9 Cr from Feb 2023. Its largest positions were Sun Pharmaceutical Industries Limited (15.0%), Dr. Reddy's Laboratories Limited (7.5%), Lupin Limited (6.6%); the ten largest together made up 62.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 77.0% of its equity. Cash and debt stood at 1.2%. Compared with Feb 2023 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
15%
Holds more cash than 15% of peers
Holdings in March 2023
Download CSVEvery line the fund disclosed, with the change against Feb 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 14.97%
- Δ weight
- up 0.28 pts
- Value
- ₹645 Cr
- Δ value
- up ₹17.4 Cr
- Status
- Added
- Weight
- 7.52%
- Δ weight
- down 0.57 pts
- Value
- ₹324 Cr
- Δ value
- down ₹21.7 Cr
- Status
- Trimmed
- Weight
- 6.63%
- Δ weight
- down 0.17 pts
- Value
- ₹286 Cr
- Δ value
- down ₹4.8 Cr
- Status
- Trimmed
- Weight
- 6.28%
- Δ weight
- down 0.10 pts
- Value
- ₹270 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 5.22%
- Δ weight
- down 0.16 pts
- Value
- ₹224 Cr
- Δ value
- down ₹4.7 Cr
- Status
- Trimmed
- Weight
- 5.14%
- Δ weight
- down 0.09 pts
- Value
- ₹221 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 4.68%
- Δ weight
- up 0.36 pts
- Value
- ₹202 Cr
- Δ value
- up ₹16.9 Cr
- Status
- Added
- Weight
- 4.26%
- Δ weight
- down 0.04 pts
- Value
- ₹184 Cr
- Δ value
- down ₹15 L
- Status
- Held
- Weight
- 4.21%
- Δ weight
- up 0.42 pts
- Value
- ₹181 Cr
- Δ value
- up ₹19.4 Cr
- Status
- Added
- Weight
- 3.93%
- Δ weight
- up 0.17 pts
- Value
- ₹169 Cr
- Δ value
- up ₹8.5 Cr
- Status
- Added
- Weight
- 3.66%
- Δ weight
- down 0.11 pts
- Value
- ₹157 Cr
- Δ value
- down ₹3.4 Cr
- Status
- Trimmed
- Weight
- 3.48%
- Δ weight
- up 0.04 pts
- Value
- ₹150 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Weight
- 3.13%
- Δ weight
- down 0.12 pts
- Value
- ₹135 Cr
- Δ value
- down ₹3.8 Cr
- Status
- Trimmed
- Weight
- 2.97%
- Δ weight
- down 0.08 pts
- Value
- ₹128 Cr
- Δ value
- down ₹2.4 Cr
- Status
- Trimmed
- Weight
- 2.95%
- Δ weight
- down 0.14 pts
- Value
- ₹127 Cr
- Δ value
- down ₹5 Cr
- Status
- Trimmed
- Weight
- 2.83%
- Δ weight
- up 0.04 pts
- Value
- ₹122 Cr
- Δ value
- up ₹2.7 Cr
- Status
- Added
- Weight
- 2.55%
- Δ weight
- up 0.07 pts
- Value
- ₹110 Cr
- Δ value
- up ₹3.8 Cr
- Status
- Added
- Weight
- 2.36%
- Δ weight
- down 0.25 pts
- Value
- ₹102 Cr
- Δ value
- down ₹9.6 Cr
- Status
- Trimmed
- Weight
- 2.23%
- Δ weight
- up 0.13 pts
- Value
- ₹95.9 Cr
- Δ value
- up ₹6.2 Cr
- Status
- Added
- Weight
- 1.85%
- Δ weight
- up 0.25 pts
- Value
- ₹79.8 Cr
- Δ value
- up ₹11.4 Cr
- Status
- Added
- Weight
- 1.76%
- Δ weight
- down 0.11 pts
- Value
- ₹75.9 Cr
- Δ value
- down ₹3.9 Cr
- Status
- Trimmed
- Weight
- 1.39%
- Δ weight
- down 0.16 pts
- Value
- ₹59.7 Cr
- Δ value
- down ₹6.2 Cr
- Status
- Trimmed
- Weight
- 1.32%
- Δ weight
- down 0.01 pts
- Value
- ₹56.8 Cr
- Δ value
- up ₹17 L
- Status
- Held
- Cash, TREPS & receivables
- Weight
- 1.25%
- Δ weight
- up 0.47 pts
- Value
- ₹53.8 Cr
- Δ value
- up ₹20.4 Cr
- Status
- Added
- Weight
- 1.11%
- Δ weight
- up 0.02 pts
- Value
- ₹47.7 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 0.89%
- Δ weight
- down 0.02 pts
- Value
- ₹38.3 Cr
- Δ value
- down ₹64 L
- Status
- Trimmed
- Weight
- 0.55%
- Δ weight
- down 0.01 pts
- Value
- ₹23.8 Cr
- Δ value
- down ₹21 L
- Status
- Trimmed
- Weight
- 0.36%
- Δ weight
- down 0.04 pts
- Value
- ₹15.3 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 0.27%
- Δ weight
- down 0.03 pts
- Value
- ₹11.8 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 0.24%
- Δ weight
- down 0.02 pts
- Value
- ₹10.5 Cr
- Δ value
- down ₹67 L
- Status
- Trimmed
What changed, Feb 2023 to Mar 2023
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Aurobindo Pharma Limitedup ₹19.4 Cr (+0.42% pts)
- Sun Pharmaceutical Industries Limitedup ₹17.4 Cr (+0.28% pts)
- Abbott India Limitedup ₹16.9 Cr (+0.36% pts)
- MedPlus Health Services Limitedup ₹11.4 Cr (+0.25% pts)
- Torrent Pharmaceuticals Limited ₹8.5 Cr (+0.17% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2023, the weight rose most in Retailing (+0.3 pts) and Pharmaceuticals & Biotechnology (+0.2 pts), and fell most in Healthcare Services (−0.3 pts) and Pharmaceuticals (−0.2 pts).
- Retailing1.6% → 1.9%+0.3 pts
- Pharmaceuticals & Biotechnology76.8% → 77.0%+0.2 pts
- Healthcare Services19.7% → 19.4%−0.3 pts
- Pharmaceuticals1.6% → 1.4%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2020 | Mar 2022 | Sep 2022 | Dec 2022 | Feb 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.4% | 76.8% | 80.0% | 78.0% | 76.8% | 77.0% |
| Healthcare Services | 19.4% | 20.8% | 18.3% | 19.6% | 19.7% | 19.4% |
| Retailing | — | — | — | 0.4% | 1.6% | 1.9% |
| Pharmaceuticals | 2.2% | 1.8% | 1.3% | 1.6% | 1.6% | 1.4% |
| Healthcare Equipment & Supplies | — | 0.6% | 0.4% | 0.3% | 0.3% | 0.3% |
Allocation in Mar 2023change vs Feb 2023
- Pharmaceuticals & Biotechnology (19)77.0%▲ 0.2 pts
- Healthcare Services (7)19.4%▼ 0.3 pts
- Retailing (1)1.9%▲ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Mar 2023
1.2%
▲ 0.5 pts vs Feb 2023
- Cash alone
- 1.3%
- cash and net receivables
- A year earlier
- 2.2%
- Mar 2022 · now ▼ 0.9 pts
- Last 12 months
- 0.3% – 2.1%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.